Melanoma
📧 Sign up to get email alerts when something new happens for Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-04-19Clinical Trial Update: Anti-MART-1 F5 Cells Plus ALVAC MART-1 Vaccine to Treat Advanced Melanoma [Phase 2]
A Phase 2 study investigating anti-MART-1 F5 cells combined with ALVAC MART-1 vaccine for advanced/metastatic melanoma was terminated; resul…
-
CLINICAL_TRIALS trial_result · 2012-04-18Clinical Trial Update: Biochemotherapy With Temozolomide for Metastatic Melanoma [Phase 2]
Phase 2 clinical trial update on biochemotherapy with temozolomide for metastatic melanoma has been terminated; results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-04-11Clinical Trial Update: Safety Study of a Liposomal Vaccine to Treat Malignant Melanoma [Phase 1]
A Phase 1 safety study of a liposomal vaccine to treat melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2012-04-10Clinical Trial Update: Anti-gp100 Cells Plus ALVAC gp100 Vaccine to Treat Advanced Melanoma [Phase 2]
Phase 2 trial evaluating anti-gp100 cells plus ALVAC gp100 vaccine in advanced/metastatic melanoma; the study was terminated with results po…
-
CLINICAL_TRIALS trial_result · 2012-03-30Clinical Trial Update: Anti-Angiogenesis Agent AG-013736 In Patients With Metastatic Melanoma [Phase 2]
Phase 2 trial of anti-angiogenesis agent AG-013736 in metastatic melanoma with results posted by Pfizer.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-03-30Clinical Trial Update: Paclitaxel and Carboplatin or Temozolomide in Treating Patients With Stage IV Melanoma [Phase 2]
Phase 2 trial comparing paclitaxel plus carboplatin versus temozolomide in stage IV melanoma; the study was terminated and results were post…
-
CLINICAL_TRIALS trial_result · 2012-03-29Clinical Trial Update: Adoptive Cell Therapy Following Non-myeloablate Chemotherapy in Metastatic Melanoma Patients [Phase 2]
This document provides a Phase 2 clinical trial update on adoptive cell therapy following non-myeloablative chemotherapy in patients with me…
-
CLINICAL_TRIALS trial_result · 2012-03-29Clinical Trial Update: Cyclophosphamide and Fludarabine Followed By an Autologous Lymphocyte Infusion and Interleukin-2 in Treating Patients With Refractory or Recurrent Metastatic Melanoma [Phase 2]
Phase 2 trial update for cyclophosphamide and fludarabine followed by autologous lymphocyte infusion and interleukin-2 in refractory or recu…
-
CLINICAL_TRIALS trial_result · 2012-03-28Clinical Trial Update: PET-CT in the Management of Patients With Stage III or IV Metastatic Melanoma
This clinical trial evaluated PET-CT for managing patients with stage III or IV metastatic melanoma and has completed.
-
CLINICAL_TRIALS trial_result · 2012-03-16Clinical Trial Update: Therapeutic Autologous Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Stage IV Melanoma [Phase 1]
Phase 1 clinical trial assessing therapeutic autologous lymphocytes in combination with cyclophosphamide and aldesleukin for Stage IV melano…
-
CLINICAL_TRIALS trial_result · 2012-03-16Clinical Trial Update: Sulindac in Preventing Melanoma in Healthy Participants Who Are at Increased Risk of Melanoma [Phase 2]
Phase 2 trial update evaluating whether sulindac can prevent melanoma in healthy individuals at increased risk; trial completed with results…
-
CLINICAL_TRIALS trial_result · 2012-03-15Clinical Trial Update: Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas [Phase 1]
Phase 1 trial evaluating carboxyamidotriazole in combination with paclitaxel for advanced solid tumors and refractory lymphomas has complete…
-
CLINICAL_TRIALS trial_result · 2012-03-15Clinical Trial Update: Cyclophosphamide and Fludarabine Followed by Vaccine Therapy, Gene-Modified White Blood Cell Infusions, and Aldesleukin in Treating Patients With Metastatic Melanoma [Phase 1]
This Phase 1 study assessed a multi-modal immunotherapy regimen for metastatic melanoma including cyclophosphamide and fludarabine chemother…
-
CLINICAL_TRIALS trial_result · 2012-03-15Clinical Trial Update: Positron Emission Tomography and CT Scan in Predicting Response in Patients With Metastatic Melanoma or Kidney Cancer Who Are Undergoing Cellular Adoptive Immunotherapy on a Surgery Branch Clinical Trial [Phase 2]
Phase 2 study evaluating whether positron emission tomography (PET) and CT imaging can predict response in patients with metastatic melanoma…
-
CLINICAL_TRIALS trial_result · 2012-03-13Clinical Trial Update: A Phase I, Randomized, Open-label, Cross-over, Pharmacokinetic Study of Genasense With and Without Dacarbazine [Phase 1]
Phase I randomized, open-label, cross-over pharmacokinetic study evaluating Genasense with and without Dacarbazine in advanced melanoma; stu…
-
CLINICAL_TRIALS withdrawal · 2012-02-22Clinical Trial Update: Interstitial Fluid Pressure (IFP) Pilot Study in Melanoma Patients [NA]
A pilot study evaluating interstitial fluid pressure in melanoma patients has been withdrawn from the registry.
-
FDA label_change · 2012-02-16FDA Approved: YERVOY — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
FDA announces a supplemental application for YERVOY (ipilimumab) submitted by E.R. Squibb & Sons, L.L.C., relating to labeling changes for t…
-
CLINICAL_TRIALS research · 2012-02-13Clinical Trial Update: A Study of Transgenic Lymphocyte Immunization (TLI) Against Telomerase in Subjects With Stage III Melanoma [Phase 2]
A Phase 2 clinical trial update for transgenic lymphocyte immunization targeting telomerase in stage III melanoma patients (Stage IIIB/IIIC)…
-
CLINICAL_TRIALS trial_result · 2012-01-31Clinical Trial Update: Melanoma Detection by Oblique-Incidence Optical Spectroscopy
A clinical trial evaluating oblique-incidence optical spectroscopy for detecting melanoma has completed. The study investigates a noninvasiv…
-
CLINICAL_TRIALS withdrawal · 2012-01-26Clinical Trial Update: IPI-Biotherapy for Patients Previously Treated With Cytotoxic Drugs With Metastatic Melanoma [Phase 1, Phase 2]
The Phase 1/2 trial of IPI-Biotherapy for metastatic melanoma in patients previously treated with cytotoxic chemotherapy has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2012-01-13Clinical Trial Update: SWOG-9430: Surgery in Treating Patients With Metastatic Melanoma [Phase 2]
Updates on a Phase 2 trial evaluating surgery for patients with metastatic melanoma; the study SWOG-9430 is completed.
-
CLINICAL_TRIALS trial_result · 2011-12-22Clinical Trial Update: A Study of Vemurafenib in Previously Treated Patients With Metastatic Melanoma [Phase 2]
Phase 2 trial of vemurafenib in patients with previously treated metastatic melanoma. Results from the study have been posted.
-
CLINICAL_TRIALS trial_result · 2011-12-21Clinical Trial Update: Therapeutic Autologous Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Metastatic Melanoma [Phase 1]
Phase 1 study of autologous lymphocytes with cyclophosphamide and aldesleukin for metastatic melanoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2011-12-13Clinical Trial Update: Interferon Alfa With or Without Combination Chemotherapy Plus Interleukin-2 in Treating Patients With Melanoma [Phase 3]
Phase 3 trial evaluating interferon alfa-2b with or without combination chemotherapy plus interleukin-2 for melanoma has completed.
-
CLINICAL_TRIALS withdrawal · 2011-12-13Clinical Trial Update: Phase 1 Biomarker Study of Anti-PDL-1 in Advanced Melanoma [Phase 1]
Phase 1 biomarker study of an anti-PD-L1 agent for advanced melanoma has been withdrawn.